GLP-1 Daily: Ozempic & Wegovy News
GLP-1 Daily: Ozempic & Wegovy News — Lantern PodcastsGLP-1 Daily: Ozempic & Wegovy News is a weekday briefing on GLP-1 drugs for patients and anyone about to start one. In about eight minutes, anchor Cassidy and cohost Silvara cover what changed today across semaglutide and tirzepatide: Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus and the new oral GLP-1 pills. Expect FDA decisions, clinical trial readouts, supply and shortage updates, safety and si... more
| Publishes | Daily | Episodes | 16 | Founded | a month ago |
|---|---|---|---|---|---|
| Categories | MedicineDaily NewsHealth & FitnessNews | ||||
Listen to this Podcast
Latest Episodes
FDA inspection reports describe mold, insects and hidden records at two Chinese suppliers of compounded semaglutide and tirzepatide ingredients, now on import alert. Plus a Health Affairs Scholar study on first-fill GLP-1 denials, and the EU drug reg... more
CBS News obtained two unverified FDA adverse-event reports of deaths after use of products sold as retatrutide, and Walmart will make Ozempic and Mounjaro free in 2027 for employees with type 2 diabetes but still won't cover GLP-1s for weight loss. P... more
Eli Lilly is moving against med spas and online sellers marketing its unapproved obesity drug retatrutide, which is still in phase 3. Separately, patent and bioequivalence hurdles suggest a generic Wegovy pill could be more than a decade away.
In th... more
Novo Nordisk's post hoc STEP UP analysis at EASD 2026 says Wegovy brought liver fat below 5 percent in 23 of 26 adults with obesity. We weigh that small, company-presented result and what the oral Wegovy pill does and doesn't change for patients.
In... more
Eli Lilly's once-daily oral GLP-1 orforglipron showed no excess cardiovascular risk against insulin glargine in the 2,749-patient ACHIEVE-4 trial, published in The Lancet. That clears a key regulatory hurdle, while an NEJM perspective warns that obes... more
An American Academy of Ophthalmology meeting study links GLP-1 use to faster second-eye NAION, as federal eye-injury cases climb to 247; plus Medicare Bridge paperwork gaps for cash-pay patients, pharmacists seeing more cash GLP-1 fills, the WHO's fi... more
Medicare's $50-a-month GLP-1 Bridge pilot is denying some obese seniors who have certain diagnoses, such as severe sleep apnea. Separately, Amylyx will present Phase 3 avexitide data for post-bariatric hypoglycemia at ObesityWeek in November.
In thi... more
Federal employee health plans will require documented intensive behavioral therapy before and during anti-obesity drug treatment in 2027, while the new ADA-EASD consensus backs GLP-1 or SGLT2 drugs early in type 2 diabetes. Plus a phase 3 oral GLP-1 ... more
Key Facts
Chart Rankings
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #8 |  Singapore/Health & Fitness/Medicine |
Apple Podcasts | #32 |  Israel/Health & Fitness/Medicine |
Apple Podcasts | #64 | Singapore/Health & Fitness |
Apple Podcasts | #116 |  Philippines/Health & Fitness/Medicine |
Apple Podcasts | #216 | Israel/Health & Fitness |
Top Medicine Podcasts
Audience Metrics
Listeners, social reach, demographics and more for this podcast.
| Gender Skew | Location | Interests | |||
|---|---|---|---|---|---|
| Professions | Age Range | Household Income | |||
| Social Media Reach | |||||
Frequently Asked Questions About GLP-1 Daily: Ozempic & Wegovy News
Where can I find podcast stats for GLP-1 Daily: Ozempic & Wegovy News?
Rephonic provides a wide range of podcast stats for GLP-1 Daily: Ozempic & Wegovy News. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to GLP-1 Daily: Ozempic & Wegovy News and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
How many listeners does GLP-1 Daily: Ozempic & Wegovy News get?
Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for GLP-1 Daily: Ozempic & Wegovy News, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
What are the audience demographics for GLP-1 Daily: Ozempic & Wegovy News?
Rephonic provides comprehensive predictive audience data for GLP-1 Daily: Ozempic & Wegovy News, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
How many subscribers and views does GLP-1 Daily: Ozempic & Wegovy News have?
To see how many followers or subscribers GLP-1 Daily: Ozempic & Wegovy News has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
How many episodes of GLP-1 Daily: Ozempic & Wegovy News are there?
GLP-1 Daily: Ozempic & Wegovy News launched a month ago and published 16 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
How do I contact GLP-1 Daily: Ozempic & Wegovy News?
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Where can I see ratings and reviews for GLP-1 Daily: Ozempic & Wegovy News?
Rephonic pulls ratings and reviews for GLP-1 Daily: Ozempic & Wegovy News from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
How do I access podcast episode transcripts for GLP-1 Daily: Ozempic & Wegovy News?
Rephonic provides full transcripts for episodes of GLP-1 Daily: Ozempic & Wegovy News. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.